Preliminary development of a Risk Factor Index to identify older adults at risk of adverse medication-related outcomes: A Delphi Study Authors: Eman Rafhi, Ieva Stupans, Julie E. Stevens, Joon Soo Park, Edwin C.K. Tan, Kate N. Wang Published: 2026 ABSTRACT BackgroundOlder adults remain susceptible to medication-related harm, particularly in the context of chronic disease management. Patients' beliefs and health literacy have been shown to influence medication-related outcomes; however, these factors are not routinely incorporated into existing strategies to minimise adverse outcomes. This study therefore aimed to develop a Risk Factor Index to assist clinicians in identifying older adults at risk of adverse medication-related outcomes.MethodsA Delphi technique was employed to achieve expert consensus in developing an index to identify older adults (≥65 years) at risk of adverse medication-related outcomes. A multidisciplinary panel of clinicians and researchers were recruited via professional networks. Participants completed an online questionnaire, drawing on their expertise. Statements reaching ≥80% agreement were retained for subsequent rounds. Open-ended responses were thematically analysed using NVivo 15.ResultsThirty-seven experts completed Round 1 and twenty-nine completed Round 2. Participants included pharmacists, doctors, nurses and academics. Consensus was reached on 7 of 15 statements in Round 1 (83.7%–97.3%) and all statements in Round 2 (82.7%–100%). Thematic analysis identified six key risk factors: age-related functional decline, multimorbidity and pharmacological complexity, barriers to understanding, economic and financial concerns, healthcare interactions, and suboptimal medicine use.ConclusionThis study identified key social and individual factors contributing to inappropriate medication use and adverse outcomes in older adults. Informed by expert consensus, the index was developed to help identify at-risk individuals. While promising, the index requires validation. Findings highlight the need for a socially informed, person-centred approach to medication management in routine practice. Introduction Among older adults, medication is the most frequently employed medical intervention, and prescribing rates in this population continue to rise.1 A key challenge in ensuring appropriate medication use in older adults is the management of multiple chronic conditions, which often necessitates complex medication regimens and contributes to polypharmacy (the concurrent use of ≥five medicines).2, 3 While the use of medications is often essential to mitigate the consequences of chronic disease, older adults also face an elevated risk of medication-related harm, including severe adverse effects, drug–drug interactions, suboptimal medicine use, medication-related falls, hospitalisations and death.4, 5, 6, 7 In Australia, it has been reported that at least 250,000 hospital admissions annually are medication-related, with one in five hospitalisations in older adults attributable to medication use.8 Suboptimal medicine use, a form of inappropriate medicine use, can result from a range of factors, including polypharmacy, non-adherence and the use of high-risk medicines such as potentially inappropriate medicines (PIMs). Despite the high risk of inappropriate medicine use in older adults, few studies have comprehensively examined how patient beliefs and health literacy contribute to this issue. Research has suggested that social and individual determinants such as socioeconomic status, beliefs, and health literacy, may be associated with non-adherence and inappropriate medicine use.9, 10, 11 However, the precise role of these factors in influencing medication outcomes remains unclear. Beliefs can present as both a barrier and facilitator to inappropriate medicine use.12, 13 Current research suggests that patients with a stronger belief in the necessity of their medicines and fewer concerns (e.g. side effects or dependency) demonstrate better adherence, with beliefs emerging as a more influential predictor of adherence compared to clinical and social factors.14, 15 Additionally, health literacy has garnered significant attention in recent years due to its ability to influence clinical outcomes.16 Health literacy is defined as a person's ability to obtain, understand and use health information that sustains their wellbeing, as well as that of others.17 Although health literacy is essential, many older Australians lack the health literacy required to manage their health.18 This is concerning considering the current literature has indicated that basic functional health literacy is fundamental in the comprehension of health-related information.19, 20 Although the influence of beliefs and health literacy on medication use has been acknowledged, further research is needed to enhance our understanding of these factors and their associations with unwanted medication-related outcomes and inappropriate medicine use. Current interventions, including pharmacist-led medication reviews and hospital discharge reconciliation programs, often overlook the social dimensions that contribute to medication-related outcomes, leaving a gap in potential strategies to reduce unwanted outcomes. Medication safety and the prevention of hospitalisations related to inappropriate medication use remain significant concerns in the Australian healthcare system.21 Despite the implementation of various strategies to mitigate these risks, fall-related hospital admissions and other adverse outcomes persist.22, 23, 24, 25 This issue, however, extends beyond Australia and represents a major global concern. A 2023 systematic review and meta-analysis reported that PIM use among older outpatients worldwide has fluctuated considerably over the past two decades, with prevalence consistently exceeding 40% in recent years, indicating a sustained international burden.26 While beliefs and health literacy have been shown to influence medication-related outcomes and the understanding of health-related information,14, 15, 20, 27 respectively, existing strategies do not incorporate these factors into efforts to minimise unwanted outcomes. To address this gap, this study will introduce the development of a tool, referred to as the Risk Factor Index, that integrates key factors such as medication beliefs and health literacy into risk assessments. This study aims to develop a Risk Factor Index that clinicians and researchers can use to identify older adults at risk of inappropriate medicine use or unwanted medication-related outcomes. The Risk Factor Index is a composite risk score designed to identify individuals who may be at increased risk of unwanted medication-related outcomes due to their social and individual circumstances. It aggregates multiple determinants of health, such as social support, language barriers, beliefs and health literacy, into a single index score. Still, the index also incorporates other relevant variables, such as functional, cognitive, or access-related factors, since these contribute meaningfully to the overall risk of adverse outcomes. Various social factor indices have been developed to capture social disadvantage, including the CDC's Social Vulnerability Index (SVI), which was originally created for disaster management and emergency response planning.28 Although designed for population-level use, the SVI has since been applied in health research, including oncology research.29 In contrast, the index developed in this study targets individual-level risk factors and is tailored to predict unwanted medication-related outcomes among older adults. To the best of our knowledge, this is the first Risk Factor Index to incorporate both social and individual-level determinants, such as beliefs and health literacy, into a single, multidimensional score. By quantifying risk, the index may support clinical decision-making, facilitate early intervention, and help tailor care plans to better meet the needs of at-risk older adults. Methods Study design and ethics This study employed the Delphi technique to achieve consensus among expert panel members, based in Australia, in developing a Risk Factor Index aimed at identifying older adults (aged 65 years and above) at risk of inappropriate medication use and unwanted medication-related outcomes. Participants were invited to complete two rounds of an online questionnaire individually, responding to the questions based on their personal expertise and experience, without the use of external references. The Delphi method was employed in the development of the Risk Factor Index as it facilitates structured consensus-building among experts, particularly to broaden knowledge in complex clinical areas.30, 31 This approach is particularly appropriate for complex clinical issues where expert judgment is critical to identifying clinically relevant risk factors. Given that the tool is intended for clinical application, the risk factors were affirmed or identified directly by experienced clinicians, ensuring their relevance and applicability in real-world practice. Ethical approval for the study was granted by the University Human Research Ethics Committee (#27039). Panel selection A multistakeholder Delphi design was employed, involving clinicians and researchers from multiple disciplines to ensure diverse professional perspectives. Clinicians and researchers including pharmacists, doctors, aged care nurses, and health academics with expertise in geriatrics were identified and invited to participate in a multidisciplinary digital panel to develop an index. Purposive sampling was used to recruit participants with relevant expertise, and a total of 59 experts were invited. Experts identified through professional networks, publications, and research records were contacted via email as part of the recruitment process. Participants were considered experts if they were a health professional and/or researcher with demonstrated expertise in geriatrics or medication management in older adults. Participants were provided with a participant information sheet and informed of the study's objectives. Consent was obtained from all participants prior to participation in the study. Delphi rounds The Delphi process and the development of the Risk Factor Index is outlined in Fig. 1.Fig. 1Fig. 1. Preparation of Delphi rounds and development of the Risk Factor Index.Fig. 1 Fig. 1. Preparation of Delphi rounds and development of the Risk Factor Index. Preparation The development of the initial Delphi questionnaire was informed by a series of prior investigations conducted by the research team, including a systematic review, descriptive study, baseline cross-sectional study, and longitudinal follow-up study (Fig. 1).32, 33, 34, 35 The systematic review synthesised existing evidence on the influence of patients' beliefs about medicines and their relationship with suboptimal medication use in community-dwelling older adults.33 The descriptive study explored the social and individual factors, including beliefs, experiences, and health literacy, that influence medication use in older adults. 32 Building on this, the cross-sectional study explored the influence of beliefs and health literacy on medication-related outcomes with a larger sample size. 34 The follow-up study further examined changes over a 6-month period and the persistence of key factors influencing medication use.35 Collectively, these investigations identified key factors contributing to unwanted medication-related outcomes in older adults. These findings were synthesised and translated into a set of preliminary statements, which formed the basis of the Round 1 Delphi survey. This approach ensured that the Delphi process was grounded in both empirical data and the existing evidence base, thereby enhancing the relevance, validity, and content coverage of the items presented to the expert panel. Round 1 survey The survey was designed to address several key themes, including beliefs, health literacy, polypharmacy, and potentially inappropriate medicine use. As mentioned, these themes were selected based on existing literature and prior research findings.32, 33, 34, 35 The survey questions were developed by the study investigators and piloted by three investigators (KW, JS, IS), with expertise in geriatrics (KW) and pharmacy (JS and IS). Revisions were made based on their feedback before the survey was distributed to the panel members. Participants were asked to rate their agreement with 15 statements using a 5-point Likert scale, ranging from “strongly disagree” to “strongly agree.” In addition, they were asked to respond to four open-ended questions and provide any further comments they wished to share. Thematic analysis of these open-ended responses identified common themes which informed the development of new statements incorporated for Round 2. Round 2 survey The second-round survey was composed of two main elements: firstly, it included statements from the first round that had already achieved a preliminary consensus level of 80% or higher; secondly, it incorporated new items that were developed through a thematic analysis of the open-ended responses provided by participants in the initial round. An optional open-ended question was also included to capture any additional comments. This approach enabled both the validation of previously agreed upon statements and the exploration of emerging themes identified through participants' qualitative feedback. Participants were asked to rate their agreement with 16 statements using a 5-point Likert scale, ranging from “strongly disagree” to “strongly agree”. Additionally, they were asked to provide any further comments. Data analysis and synthesis Data from both Delphi rounds were initially exported to SPSS version 29.0 for analysis. The demographic characteristics of expert panel members were analysed and presented using descriptive statistics, including absolute numbers and percentages of the total panel size. For the quantitative component, a consensus threshold of 80% was applied in each round to determine agreement on statements.36, 37 A statement was considered to have reached consensus if 80% or more of participants either agreed or strongly agreed, and these statements were then carried forward to the subsequent round. For the qualitative component, open-ended responses were thematically analysed separately using NVivo 15 software. Thematic analysis was conducted in accordance with the six-phase framework outlined by Braun and Clarke,38 comprising the following stages: (1) familiarisation with the data, (2) generation of initial codes, (3) identification of themes, (4) refinement of themes, (5) definition of themes, and (6) report writing. The initial coding and development of preliminary themes were undertaken by the primary researcher. These emerging themes were subsequently presented to the research team and discussed. Analytical rigor was ensured through iterative coding and refinement of themes, supported by regular discussions with the research team and maintenance of an audit trail to document coding and thematic decisions. Thematic analysis continued until data saturation was reached, defined as the point at which no new themes or concepts emerged. Through collaborative dialogue and critical reflection, themes were refined and finalised to ensure coherence and transparency in the analysis. Qualitative findings were used to refine the wording of Delphi statements and identify new or emerging concepts for inclusion in subsequent rounds. Thematic analysis was conducted until data saturation was reached. Data collection concluded once quantitative consensus was achieved and qualitative saturation was reached. Development of Risk Factor Index The Risk Factor Index was developed using a two-round Delphi process. In Round 1, statements were generated based on a review of the literature and findings from preliminary studies. Statements that achieved ≥80% consensus in the first round were retained for Round 2. In addition, thematic analysis of open-ended responses from Round 1, informed the inclusion of new statements in Round 2. An optional open-ended question was included in Round 2 to capture any additional qualitative comments. Following the Delphi rounds, statements were evaluated against pre-specified consensus criteria, and qualitative feedback was analysed thematically to identify additional themes for inclusion. Data collection concluded once quantitative consensus was achieved and qualitative saturation was reached. The statements were subsequently organised into key categories to inform the structure and domains of the Index, and reworded into concise, single-item screening questions to ensure applicability in clinical settings. The scoring system was initially developed by the research team; however, experts who participated in both Delphi rounds were invited to review the drafted index and provide additional feedback or suggestions. Based on this expert input, cut-off points were refined, with preliminary thresholds remaining subject to additional refinement during future validation phases. Results A total of 37 experts participated in Round 1, with 29 experts contributing to Round 2. Of the 29 experts in Round 2, all had also participated in Round 1, while 8 experts were only involved in the first round. While reasons for non-participation were not specifically requested, time constraints and busy schedules were commonly cited as factors influencing the decline in participation. Most participants were pharmacists (Round 1 = 59.5%, Round 2 = 58.6%), followed by doctors (Round 1 = 24.3%, Round 2 = 27.6%) (Table 1). Other professional groups included nurses (Round 1 = 10.8%, Round 2 = 6.9%) and researchers with geriatric-based experience (Round 1 = 5.4%, Round 2 = 6.9%).Table 1Characteristics of expert panel members.Round 1 (n = 37)Round 2 (n = 29)n (%)n (%)Sex Male14 (37.8)10 (34.5) Female21 (56.8)17 (58.6) Unspecified2 (5.4)2 (6.9)Occupation Pharmacist (overall)22 (59.5)17 (58.6) Pharmacist – Community, Hospital or Regulatory9 (24.3)6 (20.7) Academic pharmacist9 (24.3)9 (31.0) Consultant pharmacist4 (10.8)2 (6.9) Doctor (overall)9 (24.3)8 (27.6) General Practitioner (GP)4 (10.8)4 (13.8) Specialist2 (5.4)2 (6.9) Geriatrician2 (5.4)2 (6.9) General Surgeon1 (2.7)0 (0.0) Researcher with geriatric-based experience2 (5.4)2 (6.9) Nurse (overall)4 (10.8)2 (6.9) Aged Care Nurse2 (5.4)1 (3.4) Registered Nurse2 (5.4)1 (3.4) Area of expertise Geriatrics11 (29.7)10 (34.5) Pharmacy Practice11 (29.7)8 (27.6) Primary Care9 (24.3)7 (24.1) Medication Safety1 (2.7)1 (3.4) Regulatory pharmacy1 (2.7)0 (0.0) Public Health1 (2.7)1 (3.4) Other medical specialties a3 (8.1)2 (6.9)aOther medical specialties included surgery, unspecified specialist and/or nephrology. Table 1Characteristics of expert panel members.Round 1 (n = 37)Round 2 (n = 29)n (%)n (%)Sex Male14 (37.8)10 (34.5) Female21 (56.8)17 (58.6) Unspecified2 (5.4)2 (6.9)Occupation Pharmacist (overall)22 (59.5)17 (58.6) Pharmacist – Community, Hospital or Regulatory9 (24.3)6 (20.7) Academic pharmacist9 (24.3)9 (31.0) Consultant pharmacist4 (10.8)2 (6.9) Doctor (overall)9 (24.3)8 (27.6) General Practitioner (GP)4 (10.8)4 (13.8) Specialist2 (5.4)2 (6.9) Geriatrician2 (5.4)2 (6.9) General Surgeon1 (2.7)0 (0.0) Researcher with geriatric-based experience2 (5.4)2 (6.9) Nurse (overall)4 (10.8)2 (6.9) Aged Care Nurse2 (5.4)1 (3.4) Registered Nurse2 (5.4)1 (3.4) Area of expertise Geriatrics11 (29.7)10 (34.5) Pharmacy Practice11 (29.7)8 (27.6) Primary Care9 (24.3)7 (24.1) Medication Safety1 (2.7)1 (3.4) Regulatory pharmacy1 (2.7)0 (0.0) Public Health1 (2.7)1 (3.4) Other medical specialties a3 (8.1)2 (6.9)aOther medical specialties included surgery, unspecified specialist and/or nephrology. Characteristics of expert panel members. Other medical specialties included surgery, unspecified specialist and/or nephrology. Regarding areas of expertise, geriatrics and pharmacy practice were the most prevalent fields in both rounds, followed by primary care (see Table 1). Other areas, including medication safety, regulatory pharmacy, public health, and various medical specialties, were less represented, with proportions ranging from 2.7% to 8.1%. Consensus on statements and qualitative feedback For Round 1, consensus was reached on 7 of the 15 statements, with agreement percentages ranging from 83.7% to 97.3%, as detailed in Supplementary Table S1. In Round 2, all statements reached consensus, with agreement percentages ranging from 82.7% to 100%, as detailed in Supplementary Table S2. While consensus was reached on certain predefined factors such as beliefs through quantitative agreement on statements (≥80% consensus), additional themes emerged from qualitative analysis of open-ended expert responses. These emergent themes reflected broader factors influencing medication-related outcomes that were not explicitly captured in the initial statements. In Round 1, 37 participants provided 138 qualitative comments in response to open-ended questions. Thematic analysis identified six principal themes associated with increased risk of inappropriate medicine use and unwanted medication-related outcomes among older adults. Some themes, including age-related functional decline and economic and financial concerns, were derived exclusively from qualitative input and informed the development of new statements for Round 2. These findings are summarised in Table 2, which presents the overarching themes and subthemes that guided the refinement of item wording and the generation of additional statements. In Round 2, 29 participants completed the survey, with five providing responses to an optional open-ended question. Analysis of these responses did not reveal any new or divergent themes, and the feedback largely reinforced the statements under consideration, indicating that thematic saturation had been reached for Round 2. The Delphi process concluded after two rounds, once quantitative consensus and qualitative saturation were achieved. Following both rounds, qualitative and quantitative findings were integrated to finalise the structure of the Risk Factor Index.Table 2Summary of themes and subthemes related to factors contributing to unwanted medication-related outcomes in older adults.Major themesSub-themesMain FindingsTheme 1: Age-related functional decline•Cognitive decline•Dexterity challenges•Independence•Impaired mobility•Physiological changes in older adultsAge-related physical and cognitive impairments may reduce older adults' ability to manage medications safely and independently, increasing the risk of unwanted medication-related outcomes.Cognitive decline was the most frequently reported factor affecting appropriate medication use and contributing to adverse outcomes.Theme 2: Multimorbidity and risks in pharmacological care•Complexity of medication regimen•Multimorbidity and medication burden•Use of multiple medicines and polypharmacy•Side effects and adverse eventsThe presence of multiple chronic conditions often leads to complex medication regimens and polypharmacy, increasing the risk of medication burden, side effects, and, therefore, adverse events in older adults.Theme 3: Barriers to understanding•Cultural barrier•Language and communication barriers•Health Literacy and understanding medications•ConfusionCultural and language barriers, low health literacy, and general confusion hinder older adults' understanding of their medications, increasing the risk of misuse and adverse outcomes.Older adults with limited understanding of their medications may misuse or misinterpret instructions, leading to incorrect or inconsistent use.Healthcare professionals may contribute to misunderstandings of medication instructions by using complex medical language instead of simpler, more understandable terms.Theme 4: Economic and financial concerns•Financial cost or concern•Economic factors and cost/access to healthcareThe high cost of medications is a major barrier to medication use.Experts noted that the high costs associated with doctor visits and healthcare, in general, create significant financial strain for older adults. The limited appointment time also limits the opportunity to address all their health concerns.Limited access to urgent care services, combined with financial challenges, often forces older adults to prioritise convenience over comprehensive care, potentially delaying necessary treatments.Theme 5: Interactions with Healthcare•Relationship and time spent with healthcare professionals•Lack of coordination and support provided by healthcare team.Inadequate time spent with healthcare professionals and poor coordination within the healthcare team were commonly identified as barriers that hinder older adults' ability to understand and manage their medications correctly, contributing to adverse outcomes.However, one expert also noted that strong relationships with healthcare practitioners, while generally beneficial, could sometimes result in more frequent visits which may contribute to inappropriate prescribing and increased medication burden.“Good relationships with healthcare practitioners lead to more visits and more prescriptions which are leading to unfavourable medication-related outcomes” [P16].Theme 6: Suboptimal medicine use•Polypharmacy•Non-adherence•High risk medicines and inappropriate medicine use.Experts identified suboptimal medicine use as a significant contributor to unwanted medication-related outcomes in older adults.Taking multiple medications increases complexity and the potential for drug interactions and side effects, heightening the risk of harm.Older adults may intentionally or unintentionally fail to take medicines as prescribed, increasing the risk of adverse outcomes.“Many want to stop their medications and often do without consultation putting them at risk of withdrawal effects”.39The use of inappropriate medicines, including PIMs, is contributing to and exacerbating adverse medication-related outcomes in older adults. Table 2Summary of themes and subthemes related to factors contributing to unwanted medication-related outcomes in older adults.Major themesSub-themesMain FindingsTheme 1: Age-related functional decline•Cognitive decline•Dexterity challenges•Independence•Impaired mobility•Physiological changes in older adultsAge-related physical and cognitive impairments may reduce older adults' ability to manage medications safely and independently, increasing the risk of unwanted medication-related outcomes.Cognitive decline was the most frequently reported factor affecting appropriate medication use and contributing to adverse outcomes.Theme 2: Multimorbidity and risks in pharmacological care•Complexity of medication regimen•Multimorbidity and medication burden•Use of multiple medicines and polypharmacy•Side effects and adverse eventsThe presence of multiple chronic conditions often leads to complex medication regimens and polypharmacy, increasing the risk of medication burden, side effects, and, therefore, adverse events in older adults.Theme 3: Barriers to understanding•Cultural barrier•Language and communication barriers•Health Literacy and understanding medications•ConfusionCultural and language barriers, low health literacy, and general confusion hinder older adults' understanding of their medications, increasing the risk of misuse and adverse outcomes.Older adults with limited understanding of their medications may misuse or misinterpret instructions, leading to incorrect or inconsistent use.Healthcare professionals may contribute to misunderstandings of medication instructions by using complex medical language instead of simpler, more understandable terms.Theme 4: Economic and financial concerns•Financial cost or concern•Economic factors and cost/access to healthcareThe high cost of medications is a major barrier to medication use.Experts noted that the high costs associated with doctor visits and healthcare, in general, create significant financial strain for older adults. The limited appointment time also limits the opportunity to address all their health concerns.Limited access to urgent care services, combined with financial challenges, often forces older adults to prioritise convenience over comprehensive care, potentially delaying necessary treatments.Theme 5: Interactions with Healthcare•Relationship and time spent with healthcare professionals•Lack of coordination and support provided by healthcare team.Inadequate time spent with healthcare professionals and poor coordination within the healthcare team were commonly identified as barriers that hinder older adults' ability to understand and manage their medications correctly, contributing to adverse outcomes.However, one expert also noted that strong relationships with healthcare practitioners, while generally beneficial, could sometimes result in more frequent visits which may contribute to inappropriate prescribing and increased medication burden.“Good relationships with healthcare practitioners lead to more visits and more prescriptions which are leading to unfavourable medication-related outcomes” [P16].Theme 6: Suboptimal medicine use•Polypharmacy•Non-adherence•High risk medicines and inappropriate medicine use.Experts identified suboptimal medicine use as a significant contributor to unwanted medication-related outcomes in older adults.Taking multiple medications increases complexity and the potential for drug interactions and side effects, heightening the risk of harm.Older adults may intentionally or unintentionally fail to take medicines as prescribed, increasing the risk of adverse outcomes.“Many want to stop their medications and often do without consultation putting them at risk of withdrawal effects”.39The use of inappropriate medicines, including PIMs, is contributing to and exacerbating adverse medication-related outcomes in older adults. Summary of themes and subthemes related to factors contributing to unwanted medication-related outcomes in older adults. •Cognitive decline Cognitive decline •Dexterity challenges Dexterity challenges •Independence Independence •Impaired mobility Impaired mobility •Physiological changes in older adults Physiological changes in older adults •Complexity of medication regimen Complexity of medication regimen •Multimorbidity and medication burden Multimorbidity and medication burden •Use of multiple medicines and polypharmacy Use of multiple medicines and polypharmacy •Side effects and adverse events Side effects and adverse events •Cultural barrier Cultural barrier •Language and communication barriers Language and communication barriers •Health Literacy and understanding medications Health Literacy and understanding medications •Confusion Confusion •Financial cost or concern Financial cost or concern •Economic factors and cost/access to healthcare Economic factors and cost/access to healthcare •Relationship and time spent with healthcare professionals Relationship and time spent with healthcare professionals •Lack of coordination and support provided by healthcare team. Lack of coordination and support provided by healthcare team. •Polypharmacy Polypharmacy •Non-adherence Non-adherence •High risk medicines and inappropriate medicine use. High risk medicines and inappropriate medicine use. Qualitative data: emerging themes Thematic analysis identified six principal themes associated with increased risk of inappropriate medicine use and unwanted medication-related outcomes among older adults: (1) Age-related functional decline, (2) Multimorbidity and risks in pharmacological care, (3) Barriers to understanding, (4) Economic and financial concerns, (5) Interactions with healthcare and (6) Suboptimal medicine use. Each theme corresponds to several subthemes, as summarised in Table 2. Theme 1: age-related functional decline Expert participants' descriptions of age-related functional decline were summarised into the following: cognitive decline, dexterity challenges, reduced independence, impaired mobility and physiological changes in older adults. Cognitive decline was the most frequently reported factor contributing to inappropriate medicine use and adverse medication-related outcomes. Nearly all participants referred to issues such as “cognitive decline,” “decreased cognition,” “memory loss,” and “dementia” as key contributors to medication mismanagement in older adults. Several experts described instances where older adults forgot to take their medicines, or became confused between similar-looking medications, illustrating the practical implications of cognitive impairment in daily life. This concern also prompted many experts to highlight the role of independence as a critical influence. Descriptions such as “living alone,” “social isolation,” and “lack of support” were commonly used to illustrate how reduced independence may compromise the safe and effective use of medicines. Experts described the gradual loss of independence as both a practical and emotional challenge, with some highlighting the tension between maintaining autonomy and ensuring medication safety. The absence of external oversight or assistance was viewed as a critical factor exacerbating inappropriate medicine use. As one expert noted,“Additional factors influencing the correct use of medicines in older adults include their independence, life phase (e.g. 66 vs 96 years old), life priorities, support around them (family, carers, etc)” [P3] “Additional factors influencing the correct use of medicines in older adults include their independence, life phase (e.g. 66 vs 96 years old), life priorities, support around them (family, carers, etc)” [P3] Some participants attributed adverse outcomes to “dexterity issues”, while others addressed both the combined impact of cognitive and physical limitations, including:“cognitive function, physical function, dexterity, vision and medication factors (bottle vs. blister etc)” [P31] “cognitive function, physical function, dexterity, vision and medication factors (bottle vs. blister etc)” [P31] Impaired mobility was frequently highlighted by participants as a significant factor affecting medicine use and overall health outcomes in older adults. This concept was variously described using terms such as “mobility,” “poor physical function,” “physical status,” and “disability (physical or cognitive).” Participants emphasised that limitations in physical movement or functional capacity can hinder older adults' ability to effectively use their medicines. These challenges may include difficulty travelling to healthcare services, retrieving prescriptions, or handling medication packaging. Participants also drew attention to the broader physiological changes associated with ageing, which can alter both the effectiveness and safety of pharmacological interventions. References included “physiological factors in older adults,” “changes in physiology,” and “age-related pharmacokinetics.” Experts identified issues such as “swallowing difficulties,” “difficulty in hearing instructions,” and “hard to read instructions” as age-related challenges that complicate medicine use. These descriptions reflected the interconnectedness of biological, sensory, and cognitive changes in shaping medication experiences in later life. Theme 2: multimorbidity and risks in pharmacological care This theme explored the impact of multimorbidity and pharmacological care in older adults. Expert panel members emphasised the challenges posed by complex medication regimens, the burden of managing multiple conditions and multiple medicines. They described this complexity as both a clinical and a practical burden that heightens the risk of medication-related harm. The majority of participants reported side effects and adverse events to be common contributors to unwanted medication-related outcomes. Participants also frequently associated multimorbidity with an increased risk of polypharmacy and adverse events. Many expressed concern that the accumulation of medicines over time leads to greater exposure to adverse events and drug–drug interactions.“Unfavourable outcomes can be a result of too many medications leading to a greater risk of side effects and interactions, this compounding their health issues and increasing their risk of an adverse event” [P36] “Unfavourable outcomes can be a result of too many medications leading to a greater risk of side effects and interactions, this compounding their health issues and increasing their risk of an adverse event” [P36] Other participants described polypharmacy as an inevitable consequence of multimorbidity, reflecting a cumulative process in which each new diagnosis adds another layer of treatment.“There are generally medication available for all sorts of conditions – so as people accumulate health problems they accumulate “fixes”” [P1] “There are generally medication available for all sorts of conditions – so as people accumulate health problems they accumulate “fixes”” [P1] Experts noted that this incremental prescribing pattern often results in complex medication profiles that are difficult for both clinicians and patients to manage. Some participants highlighted that such prescribing requires careful oversight and regular review to mitigate the risks of therapeutic burden and adverse interactions. Experts also expressed concerns regarding multimorbidity and the burden of medications in the older adult population.“Older adults feel overwhelmed with the burden of managing complex medication regimens on an ongoing basis.” [P26] “Older adults feel overwhelmed with the burden of managing complex medication regimens on an ongoing basis.” [P26] These accounts collectively illustrate how multimorbidity, through both clinical complexity and treatment intensity, shapes older adults' experiences of pharmacological care. Experts viewed the safe management of medicines in this population as contingent not only on pharmacological appropriateness but also on the individual's capacity to sustain multiple treatment regimens over time. Theme 3: barriers to understanding Barriers to medication understanding were identified as cultural barriers, language and communication challenges, and most notably, limited health literacy and inadequate comprehension of medications. Health literacy and the understanding of medications were frequently highlighted by participants as key factors influencing medication-related outcomes in older adults. Many participants indicated that reduced health literacy, coupled with a limited understanding of medication regimens, often leads to unintended consequences, such as incorrect and improper use of medications. Limited health literacy was also highlighted by many participants as a significant barrier, impeding older adults' ability to engage with healthcare information and make informed decisions about their medicines.“Poor health literacy and lack of understanding of medication purpose are contributing to hospitalisation” [P28] “Poor health literacy and lack of understanding of medication purpose are contributing to hospitalisation” [P28] Still, one expert provided a nuanced perspective on the dual impact of health literacy on medication management. Different aspects of health literacy may influence outcomes in contrasting ways: older adults who are proficient at independently understanding health information may manage their medications more effectively, whereas those skilled at navigating healthcare services and engaging with multiple prescribers may accumulate additional medicines. This accumulation can increase the complexity of management and create further challenges [P16]. Language and communication barriers were similarly influential, with experts noting that medical terminology or complex instructions often impede understanding. Clear, simple communication was emphasised as essential.“We need to use simple language in explaining the use or benefits of the medicine” [P33] “We need to use simple language in explaining the use or benefits of the medicine” [P33] Several participants emphasised confusion as a contributing factor to inappropriate medicine use and adverse outcomes in older adults. While some experts broadly referred to this issue as “confusion,” others provided more specific examples, highlighting confusion arising from “similar looking or sounding medications” or from “changes to brands”. These issues were seen to complicate medication management, particularly among older adults with limited familiarity with pharmaceutical products, thereby increasing the risk of unfavourable outcomes. In addition, cultural barriers were identified by some participants as further complicating the understanding and appropriate use of medications. These were commonly described as “cultural barriers” or “cultural practices”. Experts described how cultural norms and expectations can affect adherence, comprehension, and engagement with healthcare advice, thereby shaping medication-related outcomes. Theme 4: economic and financial concerns Most experts emphasised the financial burden experienced by older adults in managing healthcare costs and accessing necessary healthcare services. Financial burden emerged as a prominent theme, with many participants highlighting the cost of medicines and healthcare as a significant barrier to appropriate medication use among older adults. This concern was described using terms such as “financial concern”, “affordability of medicines”, “financial stress”, “financial burden” and “cost”. These challenges were reported to affect older adults with fixed or limited incomes.“Cost is an issue for those in lower socio-economic areas” [P36] “Cost is an issue for those in lower socio-economic areas” [P36] Access, along with the cost of healthcare and broader economic challenges, were also reported as important factors influencing medication-related outcomes in older adults. Participants used terms such as “economic factors” and “affordability of healthcare” to describe how financial limitations and systemic barriers can impede timely and appropriate medical care. When prompted regarding factors contributing to medication-related hospitalisations, participants identified several key issues, including:“The time to get to doctors for appointment, cost of doctors visit, quick appointments not exploring issues, are all factors leading to medication-related hospitalisation” [P2] “The time to get to doctors for appointment, cost of doctors visit, quick appointments not exploring issues, are all factors leading to medication-related hospitalisation” [P2] Experts described a cascade effect in which limited financial resources, combined with practical difficulties in accessing healthcare, can exacerbate vulnerability to inappropriate medication use and adverse health outcomes. Theme 5: interactions with healthcare Numerous experts highlighted the importance of effective multidisciplinary teamwork in achieving positive health outcomes for older adults. They observed that shortcomings in care provided by health professionals were contributing to adverse outcomes in this population –such as inappropriate medication use and avoidable hospitalisations. Fragmented care and insufficient coordination among prescribers were reported to result in complex and potentially unsafe medication regimens. Uncoordinated prescribing can lead to overlapping medications, high anticholinergic burden, and inappropriate polypharmacy, particularly when older adults engage with multiple healthcare providers without effective communication across services. Such scenarios were described as compounding the challenges of medicine management and increasing the risk of adverse outcomes.“Poor prescribing patterns. Lack of coordination of care between prescribers leading to poor quality polypharmacy, over the counter medication use leading to high anticholinergic burden” [P26] “Poor prescribing patterns. Lack of coordination of care between prescribers leading to poor quality polypharmacy, over the counter medication use leading to high anticholinergic burden” [P26] Additionally, the quality of interactions (relationships) and the time allocated to consultations with healthcare professionals were considered essential. Many participants emphasised that insufficient time spent with doctors and other health professionals was contributing to suboptimal health outcomes. Nonetheless, while most experts noted that older adults were not spending sufficient time with their prescribers, resulting in suboptimal outcomes, one expert offered a contrasting perspective:“Good relationships with healthcare practitioners lead to more visits and more prescriptions, which are leading to unfavourable medication-related outcomes” [P16] “Good relationships with healthcare practitioners lead to more visits and more prescriptions, which are leading to unfavourable medication-related outcomes” [P16] Although this view was not widely shared, it underlines the complexity of the issue and introduces a valuable alternative lens on the potential unintended consequences of increased healthcare engagement. Theme 6: suboptimal medicine use Among the various forms of suboptimal medicines use, non-adherence emerged as a commonly reported issue by experts, often reporting non-adherence as a factor leading to unfavourable outcomes. Older adults were described as frequently struggling to follow prescribed regimens, whether due to personal preferences, perceived burden, or timing of their medications. Some participants emphasised that medications are often discontinued or adjusted without consultation, placing patients at risk of complications.“Many want to stop their medications and often do without consultation putting them at risk of withdrawal effects” [P36]. “Many want to stop their medications and often do without consultation putting them at risk of withdrawal effects” [P36]. Polypharmacy was reported to further exacerbate these challenges. As the number of medications increases, the complexity of management rises, heightening the likelihood of drug–drug interactions, non-adherence and other medication-related problems. Experts highlighted that this cumulative burden overwhelms patients, intensifying non-adherence and contributing to suboptimal health outcomes. Participants also raised concerns regarding the ongoing use of high-risk or potentially inappropriate medications (PIMs) in older adults. Some identified PIM use as a key contributor to adverse health outcomes, highlighting that it often leads to serious consequences, including an increased risk of medication-related harm and preventable hospitalisations. Development of index – based on Delphi consensus and thematic saturation By the conclusion of Round 2, all statements had reached ≥80% consensus and were considered for inclusion in the Index. Thematic saturation was also achieved, indicating that no new themes emerged. The consensus statements and qualitative findings were grouped into key themes, forming the structure and seven domains of the 16-item Risk Factor Index (Table 3). Feedback from the optional open-ended question did not reveal any additional or divergent themes, supporting the completeness of the Index. Although the Index reflected expert consensus, it had not yet undergone psychometric validation; further research is required to evaluate its reliability, validity, and practical use in clinical settings.Table 3Risk Factor Index for identifying older adults at risk of inappropriate medicine use or unwanted medication-related outcomes (drafted index). Table 3Risk Factor Index for identifying older adults at risk of inappropriate medicine use or unwanted medication-related outcomes (drafted index). Risk Factor Index for identifying older adults at risk of inappropriate medicine use or unwanted medication-related outcomes (drafted index). Discussion This study represents the first comprehensive investigation of expert opinions on the factors contributing to adverse medication-related outcomes in older adults. Additionally, it is the first to develop a Risk Factor Index designed for use by clinicians and researchers to systematically identify older adults at elevated risk of inappropriate medication use or negative health outcomes. The principal findings highlight a consensus among experts that patients' beliefs about medicines and levels of health literacy are significant determinants influencing both inappropriate medication use and adverse outcomes in this population. Beyond these factors, the study also identified a range of additional social and individual contributors that exacerbate risk. These include age-related functional decline, the presence of multiple chronic conditions (multimorbidity), complexities in pharmacological management, barriers related to communication and comprehension, financial constraints, limited interactions or poor support by healthcare providers, and patterns of suboptimal medicine use. Collectively, these findings accentuate the multifaceted nature of medication-related risks in older adults and emphasise the need for a holistic approach in clinical assessment and intervention. Consistent with existing literature,39, 40 and the findings from preliminary studies,33, 34, 35 experts agreed that both patients' beliefs about medicines and their levels of health literacy significantly influence medication-related outcomes in older adults. The literature often emphasises that a stronger belief in the necessity of medications, coupled with fewer concerns about potential harms, is associated with increased adherence and appropriate medication use.40, 41 However, in the current study, expert consensus was reached only on the positive influence of necessity beliefs in promoting appropriate medicine use. Given this, clinicians may benefit from actively assessing patients' perceived necessity for their medications, as it may serve as a more consistent indicator of medication adherence than concern-related beliefs. Biological and clinical complexities were frequently identified by experts as key contributors to inappropriate medicine use and adverse outcomes in older adults. They emphasised the significant impact of age-related functional decline, such as reduced cognitive capacity, frailty, and impaired dexterity, alongside multimorbidity and the associated challenges of managing complex medication regimens. While some aspects of clinical complexity, such as polypharmacy, can be mitigated through medication reviews or deprescribing strategies, age-related functional decline is an inherent part of the ageing process and cannot be entirely avoided. Therefore, it is essential that healthcare professionals account for these functional limitations when evaluating medication safety and appropriateness in older adults, ensuring that treatment plans are realistic, manageable, and tailored to individual capabilities. Importantly, the index developed in this study is designed to capture not only these recognised clinical challenges but also the more nuanced social and individual contributors, such as beliefs, health literacy, and financial concerns, that are often overlooked in routine care. Barriers to communication and understanding represent a significant obstacle to the safe and appropriate use of medicines in older adults. Experts in this study identified cultural differences, language proficiency, limited health literacy, and ineffective communication as factors impeding optimal medication use. In addition, structural issues, such as limited consultation time with healthcare professionals, were also reported as contributing to suboptimal outcomes. These findings highlight the importance of effective, patient-centred communication in promoting medication safety. Notably, this study supports the broader evidence that individuals who report strong, trusting relationships with their healthcare providers are more likely to experience favourable health outcomes,11, 42, 43, 44 highlighting the role of relational continuity in mitigating risk and enhancing therapeutic success. The index developed in this study incorporates these barriers as important risk factors, enabling clinicians to identify older adults who may be vulnerable to medication-related harm. When an individual is flagged as being at risk, it is essential that underlying barriers, such as health literacy, communication challenges, or cultural factors, are explored and addressed as part of a comprehensive care approach. Financial constraints are a well-recognised barrier to effective medication use among older adults, consistently highlighted in the literature and further supported by expert input in this study.45 Cost-related barriers, such as the inability to afford medicines or the decision to ration medications, can lead to non-adherence, underuse, or discontinuation of treatment. Suboptimal medicine use (including polypharmacy, use of high-risk or inappropriate medications, and inconsistent adherence) was also highlighted as a major factor associated with poor outcomes. These issues often intersect, as financial constraints may influence how older adults navigate complex medication regimens. For example, individuals prescribed multiple medicines may selectively omit or alter their use of medications based on cost, which can compromise treatment efficacy and safety. The inclusion of these factors within the developed index ensures that clinicians are prompted to consider both financial and medication-related risks when assessing an older adult's vulnerability. Identifying an individual at risk through the index should prompt further inquiry into both the affordability of treatment and the appropriateness of their current medication regimen. Nevertheless, several statements did not achieve consensus among the expert panel. These included items relating to older adults' beliefs about medicines (e.g., that stronger necessity beliefs lead to better medicine use, or that concerns decrease adherence), the relationship between polypharmacy and outcomes (e.g., higher risk of falls or hospitalisation), and the influence of doctor–patient trust or health literacy on medication use and adverse outcomes (presented in Supplementary Table S1). Lack of consensus may reflect variability in clinical experience, differing interpretations of the evidence, or the context-specific nature of these relationships. While some experts may observe that older adults with strong necessity beliefs adhere better to treatment, others may note that adherence is influenced by multiple social, cognitive, and environmental factors. Similarly, the relationship between polypharmacy and adverse outcomes such as falls or hospitalisation may be moderated by the appropriateness of the medicines, patient comorbidities, or care support. These findings highlight areas of complexity and uncertainty, suggesting that further research may be needed to clarify these particular associations, or that some factors may be context-dependent. Implications for practice The findings of this study emphasise the multifaceted social and individual factors that contribute to inappropriate medicine use and unwanted medication-related outcomes in older adults. The index offers a practical and clinically relevant tool to support the early identification of older adults at risk of inappropriate medicine use and adverse outcomes. By incorporating key social and functional factors, such as health literacy, beliefs, financial concerns, and age-related decline, the index provides clinicians with a structured means to assess risk beyond traditional clinical parameters. Its use can complement existing practices such as medication reviews, home visits, and comprehensive care planning, by drawing attention to non-clinical drivers of suboptimal medicine use that may otherwise go unrecognised. When integrated into routine care, the index can assist healthcare professionals in targeting interventions more effectively, personalising support, and ultimately improving medication safety and outcomes for older adults. However, while the development of the index is grounded in expert consensus and evidence, it is important to note that further validation is required to confirm its predictive accuracy, clinical utility, and feasibility in practice. Future studies will prioritise validating the index to establish its reliability, predictive value, and utility in real-world clinical practice. Strengths and limitations This study has several strengths and limitations. To our knowledge, it is the first to explore expert opinion on factors contributing to adverse medication-related outcomes in older adults and to develop a Risk Factor Index based on both expert consensus and current literature. The Delphi panel initially comprised 37 experts in round one and 29 in round two, representing nine distinct professional disciplines. Each round was piloted by three pharmacists, including one with geriatric expertise, ensuring methodological rigor. However, one limitation is the inherent subjectivity and potential for expert bias, as the findings reflect the perspectives of the selected panel members. That said, the Delphi included health professionals from a diverse range of backgrounds, which strengthens the breadth of viewpoints considered. Another limitation is that the Delphi method depends on expert consensus rather than empirical data. Experts were not required to support their responses with real-life examples or documented evidence, which may limit the robustness and objectivity of the consensus. Nonetheless, given the panel's professional expertise, it is reasonable to conclude that their opinions regarding factors contributing to unwanted medication-related outcomes are well-informed and aligned with current clinical knowledge. Conclusion Through expert consensus, a range of key factors leading to adverse health outcomes and inappropriate medicine use in older adults were identified, including health beliefs, health literacy, age-related functional decline, multimorbidity, barriers to understanding, economic and financial concerns, interactions with healthcare and suboptimal medicine use. All of which intersect to influence medication safety and effectiveness in this vulnerable population. In response to these findings, the Risk Factor Index was developed as a practical tool to support clinicians in proactively identifying older adults who may be at greater risk. While the index is informed by both literature and expert consensus, it has yet to undergo formal validation and should be applied with caution until further studies assess its reliability and predictive utility. This study reinforces the importance of adopting a person-centred, socially-informed approach to medication management in older adults and provides a foundation for future evidence-based interventions. CRediT authorship contribution statement Eman Rafhi: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Writing – original draft, Writing – review & editing. Ieva Stupans: Supervision, Writing – review & editing. Julie E. Stevens: Supervision, Writing – review & editing. Joon Soo Park: Supervision, Formal analysis, Writing – review & editing. Edwin C.K. Tan: Supervision, Writing – review & editing. Kate N. Wang: Supervision, Writing – review & editing. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Declaration of competing interest The authors declare that there are no conflicts of interest.